Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-25-005068
Filing Date
2025-01-21
Accepted
2025-01-21 17:06:53
Documents
5
Effectiveness Date
2025-01-21

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0227675-s8_lomond.htm S-8 53753
2 OPINION OF SNELL & WILMER L.L.P ea022767501ex5-1_lomond.htm EX-5.1 8474
3 CONSENT OF EISNERAMPER LLP ea022767501ex23-1_lomond.htm EX-23.1 2037
4 FILING FEE TABLE ea022767501ex-fee_lomond.htm EX-FILING FEES 14281
5 GRAPHIC ex5-1_001.jpg GRAPHIC 10461
  Complete submission text file 0001213900-25-005068.txt   94323
Mailing Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901
Business Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901 561 464 2841
Lomond Therapeutics Holdings, Inc. (Filer) CIK: 0001900520 (see all company filings)

IRS No.: 872959575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284390 | Film No.: 25543238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)